Skip to main content
Caplight Logo









Bio-Me AS

Bio-Me AS

Private
OsloHealthcare & Life Scienceshttps://bio-me.com/

Last Round

Grant

Jun 28, 2021

Total Funding Raised

$2.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Bio-Me AS is a biotechnology company that provides Precision Microbiome Profiling (PMP™) services and develops microbiome-based molecular diagnostics with a focus on women's health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

microbiome analysisqPCRprecision medicineprecision microbiome profilingPMPgut health screeningbiotech servicesbiomarker discoveryclinical trial supportnext-generation sequencingNGSmicrobiome testingdiagnostic panelassay developmentgut microbiomemicrobiome sequencing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bio-Me AS Comparables

Compare Bio-Me AS with similar companies based on industry and business-model similarity.

Bio-Me AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genetic Analysis AS
82%
SeqBiome Ltd
78%
Cmbio
77%

Bio-Me AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 28, 2021
VC RoundJun 10, 2021
GrantApr 23, 2020
Pre SeedNov 20, 2018
AcceleratorAug 28, 2018

Key People

Founding team and executive leadership

Arne Materna

Chief Executive Officer

Executive Team

Warren Flood

Chief Executive Officer

Executive Team

Bio-Me AS Investors

Notable investors and investment history

Bio-Me AS investors
InvestorRounds
Katapult OceanAccelerator
The Research Council of NorwayGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 89% MoM, reaching 6K.

  • Jan 25, 2026

    Monthly visitors grew 70% MoM, reaching 3.7K.

Bio-Me AS Filings

Explore SEC and related filing metadata, where available.

Bio-Me AS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bio-Me AS's valuation, stock price, and market status.

Is Bio-Me AS a public or private company?

Bio-Me AS is a private company.

What is the current stock price of Bio-Me AS?

Bio-Me AS is a private company with no public stock price. No recent secondary market data is available.

How much is Bio-Me AS worth (valuation)?

Valuation information for Bio-Me AS is not publicly available.

Can I buy Bio-Me AS stock?

Bio-Me AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bio-Me AS's last funding round?

Bio-Me AS's most recent funding round was Grant on June 28, 2021.

Who are the main investors in Bio-Me AS?

Key investors in Bio-Me AS include Katapult Ocean, The Research Council of Norway.

Will Bio-Me AS IPO soon?

No public IPO plans have been announced for Bio-Me AS.

How can I track Bio-Me AS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bio-Me AS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range12
Year Founded2016
Last FundingJun 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?